BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 34753072)

  • 1. Efficacy of Ninjin'yoeito in treating severe coronavirus disease 2019 in patients in an intensive care unit.
    Aomatsu N; Shigemitsu K; Nakagawa H; Morooka T; Ishikawa J; Yamashita T; Tsuruoka A; Fuke A; Motoyama K; Kitagawa D; Ikeda K; Maeda K; Shirano M; Rinka H
    Neuropeptides; 2021 Dec; 90():102201. PubMed ID: 34753072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria.
    Barrasa H; Rello J; Tejada S; Martín A; Balziskueta G; Vinuesa C; Fernández-Miret B; Villagra A; Vallejo A; San Sebastián A; Cabañes S; Iribarren S; Fonseca F; Maynar J;
    Anaesth Crit Care Pain Med; 2020 Oct; 39(5):553-561. PubMed ID: 32278670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High risk of malnutrition among hospitalised coronavirus disease 2019 (COVID-19) patients is associated with mortality and other clinical outcomes.
    Guðnadóttir SD; Gunnarsdóttir I; Hernandez UB; Ingadóttir ÁR
    Clin Nutr ESPEN; 2024 Jun; 61():1-7. PubMed ID: 38777420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU: A Systematic Review and Meta-analysis.
    Tan E; Song J; Deane AM; Plummer MP
    Chest; 2021 Feb; 159(2):524-536. PubMed ID: 33069725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of Ninjin'yoeito along with iron supplementation therapy for preoperative anemia, fatigue, and anxiety in patients with gynecological disease: an open-label, single-center, randomized phase-II trial.
    Yagi T; Sawada K; Miyamoto M; Kinose Y; Nakagawa S; Takiuchi T; Kodama M; Kobayashi E; Hashimoto K; Mabuchi S; Tomimatsu T; Yoshino K; Kimura T
    BMC Womens Health; 2022 Jun; 22(1):229. PubMed ID: 35701778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
    Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M
    Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.
    Takayama S; Namiki T; Ito T; Arita R; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Kainuma M; Nochioka K; Takagi A; Mimura M; Yamaguchi T; Ishii T
    Trials; 2020 Oct; 21(1):827. PubMed ID: 33008479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with critical care requirements in diabetic patients treated with dexamethasone for COVID-19 infection in the first wave of the pandemia.
    Batule S; Soldevila B; Figueredo C; Julián MT; Egea-Cortés L; Reyes-Ureña J; Casabona J; Mateu L; Paredes R; Clotet B; López R; Puig-Domingo M; Alonso N
    Front Endocrinol (Lausanne); 2022; 13():1009028. PubMed ID: 36619546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of functional recovery via neurorepair mechanisms by the traditional Japanese Kampo medicine, Ninjin'yoeito, and physical exercise in a rat ischemic stroke model.
    Tani A; Sakakima H; Otsuka S; Mizuno K; Nakanishi K; Norimatsu K; Takada S; Matsuoka T; Matsuzaki R; Nakakogawa T; Maruyama I
    J Ethnopharmacol; 2023 Feb; 302(Pt B):115927. PubMed ID: 36402237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity May Not Be Associated with 28-Day Mortality, Duration of Invasive Mechanical Ventilation and Length of Intensive Care Unit and Hospital Stay in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus-2: A Retrospective Cohort Study.
    Pouwels S; Ramnarain D; Aupers E; Rutjes-Weurding L; van Oers J
    Medicina (Kaunas); 2021 Jun; 57(7):. PubMed ID: 34210077
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylactic efficacy of ninjin'yoeito for oxaliplatin-induced cumulative peripheral neuropathy in patients with colorectal cancer receiving postoperative adjuvant chemotherapy: a randomized, open-label, phase 2 trial (HOPE-2).
    Motoo Y; Tomita Y; Fujita H
    Int J Clin Oncol; 2020 Jun; 25(6):1123-1129. PubMed ID: 32232692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
    Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
    JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health outcomes and economic burden of hospitalized COVID-19 patients in the United States.
    Di Fusco M; Shea KM; Lin J; Nguyen JL; Angulo FJ; Benigno M; Malhotra D; Emir B; Sung AH; Hammond JL; Stoychev S; Charos A
    J Med Econ; 2021; 24(1):308-317. PubMed ID: 33555956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study).
    Namiki T; Takayama S; Arita R; Ishii T; Kainuma M; Makino T; Mimura M; Yoshino T; Nogami T; Arai M; Sato J; Tanaka K; Nakae H; Igari H; Ozawa Y; Shiko Y; Kawasaki Y; Nezu M; Ito T
    Trials; 2021 Jan; 22(1):23. PubMed ID: 33407828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study on the efficacy of Ninjin'yoeito on fatigue in patients with interstitial pneumonia.
    Kushima H; Kinoshita Y; Fujita M; Ishii H
    Neuropeptides; 2021 Oct; 89():102178. PubMed ID: 34298370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of Ninjin'yoeito for Chronic Obstructive Pulmonary Disease Patients with Frailty.
    Hirai K; Homma T; Matsunaga T; Akimoto K; Yamamoto S; Suganuma H; Kashima A; Sato H; Ebato T; Miyata Y; Ohta S; Inoue H; Kusumoto S; Suzuki S; Tanaka A; Sagara H
    J Altern Complement Med; 2020 Aug; 26(8):750-757. PubMed ID: 32551796
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study.
    Murthy S; Archambault PM; Atique A; Carrier FM; Cheng MP; Codan C; Daneman N; Dechert W; Douglas S; Fiest KM; Fowler R; Goco G; Gu Y; Guerguerian AM; Hall R; Hsu JM; Joffe A; Jouvet P; Kelly L; Kho ME; Kruisselbrink RJ; Kumar D; Kutsogiannis DJ; Lamontagne F; Lee TC; Menon K; O'Grady H; O'Hearn K; Ovakim DH; Pharand SG; Pitre T; Reel R; Reeve B; Rewa O; Richardson D; Rishu A; Sandhu G; Sarfo-Mensah S; Shadowitz E; Sligl W; Solomon J; Stelfox HT; Swanson A; Tessier-Grenier H; Tsang JLY; Wood G;
    CMAJ Open; 2021; 9(1):E181-E188. PubMed ID: 33688026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes.
    Al-Salameh A; Lanoix JP; Bennis Y; Andrejak C; Brochot E; Deschasse G; Dupont H; Goeb V; Jaureguy M; Lion S; Maizel J; Moyet J; Vaysse B; Desailloud R; Ganry O; Schmit JL; Lalau JD
    Diabetes Metab Res Rev; 2021 Mar; 37(3):e3388. PubMed ID: 32683744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.